April 25, 2022
Via: medicaldevice-network.comQuanterix has received Breakthrough Device designation from the US Food and Drug Administration (FDA) for its Simoa neurofilament light chain (NfL) plasma test for multiple sclerosis (MS). The blood-based assay has obtained the designation as a prognostic aid for evaluating […]
March 28, 2024
April 19, 2024